Novo Holdings
Venture capital
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
13Deep-tech portfolio10 active
3Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Relation Therapeutics
25Co-investorsShare a portfolio company
Portfolio · 13 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Relation Therapeutics | Biotech | Active | Dec 9, 2025 | $116.4M |
| Supira Medical | Medtech | Active | Apr 3, 2025 | $220.7M |
| Abvance Therapeutics | Biotech | Active | — | — |
| Alveus Pharma | Biotech | Active | — | — |
| Antag Therapeutics | Biotech | Active | — | — |
| Aspect Biosystems | Biotech | Active | — | — |
| Basis | Biotech | Active | — | — |
| Crystalys | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| Newleos | Biotech | Active | — | — |
| Atea Pharmaceuticals | Biotech | Public | May 29, 2020 | $155.9M |
| Cardior Pharmaceuticals | Biotech | Acquired | — | — |
| Hemab Therapeutics | Biotech | Public | — | — |
Peer ranks
Portfolio size#36
Portfolio exits#69
Raises, 12 months#22
Co-investors#79
Co-investors
- Andera PartnersVenture capital2 shared
- Jeito CapitalVenture capital2 shared
- RA CapitalVenture capital2 shared
- Access BiotechnologyVenture capital1 shared
- Asahi Kasei Corporate Venture CapitalVenture capital1 shared
- Avoro Capital AdvisorsVenture capital1 shared
- BiogenVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Cormorant Asset ManagementVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
Sectors
- Biotech12
- Medtech1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.